Teva appoints Amir Weiss as Chief Accounting Officer, replacing Andrew Weil

TEVA PHARMACEUTICAL INDUSTRIES LTD

Andrew Weil steps down as Chief Accounting Officer effective November 24, 2021.
Amir Weiss promoted from VP Finance and Corporate Controller to SVP and Chief Accounting Officer, effective same date.
Weiss's base salary increased to 840,000 NIS; eligible for 50% target annual cash incentive and equity awards.
Weiss joined Teva in 2012 and holds an MA in law, MBA, and CPA.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Amir Weiss

Senior Vice President and Chief Accounting Officer

TEVA · TEVA PHARMACEUTICAL INDUSTRIES LTD

Effective: 2021-11-24
Filed: November 24, 2021, 6:59 PM ET

Amir Weiss, currently Vice President of Finance and Corporate Controller, was promoted to Senior Vice President and Chief Accounting Officer, effective November 24, 2021.

Departed

Andrew Weil

Chief Accounting Officer

TEVA · TEVA PHARMACEUTICAL INDUSTRIES LTD

Effective: 2021-11-24
Successor: Amir Weiss
Filed: November 24, 2021, 6:59 PM ET

Andrew Weil, Teva’s Chief Accounting Officer, will step down from his role as Chief Accounting Officer, effective November 24, 2021.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Amir Weiss was appointed as Senior Vice President and Chief Accounting Officer at TEVA PHARMACEUTICAL INDUSTRIES LTD.

Action: promoted
Role: Senior Vice President and Chief Accounting Officer

Exact text from the filing

Amir Weiss, currently Vice President of Finance and Corporate Controller, was promoted to Senior Vice President and Chief Accounting Officer, effective November 24, 2021.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Andrew Weil departed as Chief Accounting Officer at TEVA PHARMACEUTICAL INDUSTRIES LTD.

Action: stepped down
Role: Chief Accounting Officer

Exact text from the filing

Andrew Weil, Teva’s Chief Accounting Officer, will step down from his role as Chief Accounting Officer, effective November 24, 2021.

View on SEC.gov

TEVA PHARMACEUTICAL INDUSTRIES LTD filing history →

Source: SEC EDGAR

accession 0001193125-21-339389

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.